Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class IITerminatedD-1081-2019

Drug recall · April 17, 2019

Losartan 50mg Tablet recall

Why: CGMP Deviations; Detection of trace amounts of an unexpected impurity found in an active pharmaceutical ingredient (API) - N-Methylnitrosobutyric acid (NMBA).

Class II: could cause temporary or reversible health problems; serious harm is remote.

The recall

Product

Losartan 50mg Tablet, 30 count each blister card.

Lots / codes

70518-0588-01, Lot #: J0328416-101518, Exp. Date: 10/2019

Quantity
33 blister cards of 30 = 990 tablets
Company
RemedyRepack Inc., Indiana, PA
Distribution
Product was distributed to one sole customer, Miami, FL.
Initiated
March 14, 2019 · Voluntary: Firm initiated
Classified
April 5, 2019
Reported
April 17, 2019
Ended
April 11, 2019
How notified
Letter

The drug: prices, other makers, shortages

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Watch Losartan

One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.